News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,846 Results
Type
Article (86126)
Company Profile (649)
Press Release (753071)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232268)
Career Advice (4125)
Deals (39712)
Drug Delivery (126)
Drug Development (90805)
Employer Resources (198)
FDA (18004)
Job Trends (17326)
News (395632)
Policy (39677)
Tag
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (81)
Alliances (56687)
ALS (80)
Alzheimer's disease (1475)
Antibody-drug conjugate (ADC) (144)
Approvals (17996)
Artificial intelligence (228)
Autoimmune disease (27)
Automation (12)
Bankruptcy (403)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (447)
Bladder cancer (76)
Brain cancer (27)
Breast cancer (235)
Cancer (2072)
Cardiovascular disease (143)
Career advice (3532)
Career pathing (34)
CAR-T (161)
Cell therapy (449)
Cervical cancer (17)
Clinical research (72890)
Collaboration (798)
Compensation (451)
Complete response letters (28)
COVID-19 (2836)
CRISPR (44)
C-suite (226)
Cystic fibrosis (99)
Data (1910)
Decentralized trials (2)
Denatured (45)
Depression (39)
Diabetes (192)
Diagnostics (6768)
Digital health (10)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (121)
Drug pricing (96)
Drug shortages (17)
Duchenne muscular dystrophy (84)
Earnings (95498)
Editorial (37)
Employer branding (25)
Employer resources (167)
Events (128669)
Executive appointments (636)
FDA (18984)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (670)
Gene editing (101)
Generative AI (22)
Gene therapy (319)
GLP-1 (741)
Government (5110)
Grass and pollen (4)
Guidances (42)
Healthcare (20751)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (129)
Indications (25)
Infectious disease (2952)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (44)
Intellectual property (88)
Interviews (812)
IPO (17749)
IRA (38)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (543)
Leadership (22)
Legal (10063)
Liver cancer (73)
Lung cancer (295)
Lymphoma (138)
Machine learning (6)
Management (65)
Manufacturing (294)
MASH (69)
Medical device (14339)
Medtech (14344)
Mergers & acquisitions (22321)
Metabolic disorders (607)
Multiple sclerosis (80)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (23)
Neuroscience (1983)
NextGen: Class of 2025 (7666)
Non-profit (5058)
Now hiring (40)
Obesity (328)
Opinion (271)
Ovarian cancer (70)
Pain (72)
Pancreatic cancer (68)
Parkinson's disease (135)
Partnered (20)
Patents (206)
Patient recruitment (96)
Peanut (48)
People (64947)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22525)
Phase II (31693)
Phase III (23821)
Pipeline (1052)
Policy (142)
Postmarket research (3542)
Preclinical (10161)
Press Release (72)
Prostate cancer (93)
Psychedelics (34)
Radiopharmaceuticals (255)
Rare diseases (369)
Real estate (7384)
Recruiting (75)
Regulatory (26453)
Reports (57)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (5)
RSV (34)
Schizophrenia (70)
Series A (127)
Series B (74)
Service/supplier (25)
Sickle cell disease (47)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4286)
State (2)
Stomach cancer (12)
Supply chain (53)
Tariffs (38)
The Weekly (82)
Vaccines (737)
Venture capitalists (41)
Weight loss (228)
Women's health (37)
Worklife (20)
Date
Today (137)
Last 7 days (739)
Last 30 days (2237)
Last 365 days (29583)
2025 (9112)
2024 (34412)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (54)
Alaska (6)
Arizona (250)
Arkansas (8)
Asia (49880)
Australia (8798)
California (5462)
Canada (1624)
China (503)
Colorado (176)
Connecticut (221)
Delaware (132)
Europe (114164)
Florida (716)
Georgia (151)
Hawaii (1)
Idaho (64)
Illinois (459)
India (25)
Indiana (279)
Iowa (10)
Japan (138)
Kansas (111)
Kentucky (17)
Louisiana (8)
Maine (67)
Maryland (869)
Massachusetts (4286)
Michigan (187)
Minnesota (325)
Mississippi (2)
Missouri (55)
Montana (25)
Nebraska (26)
Nevada (55)
New Hampshire (51)
New Jersey (1544)
New Mexico (28)
New York (1552)
North Carolina (1020)
North Dakota (8)
Northern California (2357)
Ohio (168)
Oklahoma (13)
Oregon (45)
Pennsylvania (1168)
Puerto Rico (12)
Rhode Island (24)
South America (1648)
South Carolina (10)
South Dakota (1)
Southern California (2041)
Tennessee (42)
Texas (756)
United States (20570)
Utah (121)
Virginia (108)
Washington D.C. (40)
Washington State (522)
West Virginia (2)
Wisconsin (45)
839,846 Results for "belite bio llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
April 30, 2025
·
3 min read
Press Releases
Belite Bio to Participate in the Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
Belite Bio Announces Registered Direct Offering of $15 Million
February 5, 2025
·
3 min read
Press Releases
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
March 18, 2025
·
1 min read
Press Releases
Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 17, 2025
·
11 min read
Press Releases
Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
·
1 min read
Press Releases
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
February 27, 2025
·
5 min read
Biotech Beach
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”) today announced the presentation at Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2024) being held May 5 – 9, 2024, in Seattle, WA.
May 1, 2024
·
5 min read
Policy
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
Belite Bio, Inc announces that its lead pipeline, Tinlarebant, has been granted Sakigake Designation by the Ministry of Health, Labour and Welfare in Japan for the treatment of STGD1.
June 12, 2024
·
5 min read
Business
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
Belite Bio, Inc announced its financial results for the first quarter ended March 31, 2024 and provided a general business update.
May 13, 2024
·
10 min read
1 of 83,985
Next
